Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01831921 · ClinicalTrials.gov registry record · NA

Latinos Combating Diabetes

A NA study, sponsored by Wake Forest University Health Sciences.

Completed
Registry status
NA
Development phase
225
Enrollment target

NCT01831921: Completed NA study, sponsored by Wake Forest University Health Sciences.

NCT01831921 is a NA study that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 225 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (84% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01831921, a NA study, has completed, sponsored by Wake Forest University Health Sciences.

COMPLETED
Registry status
NA
Development phase
225 participants
Enrollment target

Study Summary

The investigators plan to test two different strategies for weight loss and diabetes prevention in the Latino community in and around Forsyth County, North Carolina. The study is designed to test the hypothesis that a lifestyle weight-loss program implemented within the Latino community will have a more beneficial and clinically meaningful impact on hemoglobin A1c (HbA1c), insulin metabolism, and markers of the metabolic syndrome when compared to an enhanced usual care condition. This lifestyle intervention will include group-based sessions promoting healthy eating, increased physical activity and weight loss. These sessions will be delivered by lay community members, known as Latino Health Advisors (LHAs). The enhanced usual care group will consist of individual counseling with are registered dietitian and uses existing community resources to assist participants in making healthier lifestyle choices.

Primary Outcome

Mean hemoglobin A1c in both treatment groups at 6, 12, 18, and 24 months will be assessed.

Interventions

  • BEHAVIORAL Counseling
  • BEHAVIORAL Lifestyle Weight Loss

Trial Details

FieldValue
Enrollment Target 225 participants
Start Date 2014-01
Est. Completion 2017-06-30
Phase NA
Wake Forest University Health Sciences

1,140 total trials

What the finished NCT01831921 record still lists

NCT01831921 is an interventional study that assigns participants to a tested intervention. The registered 225 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (84% lower).

The record links to 0 conditions, and to 2 interventions - of which Counseling is the first listed.

NCT01831921 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01831921 about?

NCT01831921 is a clinical study titled "Latinos Combating Diabetes". The investigators plan to test two different strategies for weight loss and diabetes prevention in the Latino community in and around Forsyth County, North Carolina. The study is designed to test the hypothesis that a lifestyle weight-loss program implemented within the Latino community will have a ...

What is the current status of trial NCT01831921?

This trial is currently completed. It is a NA study. The enrollment target is 225 participants. The study started on 2014-01. Estimated completion is 2017-06-30.

What interventions are being tested in trial NCT01831921?

The interventions under investigation include: Counseling (BEHAVIORAL), Lifestyle Weight Loss (BEHAVIORAL).

Who is sponsoring clinical trial NCT01831921?

This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01831921's enrollment target sits among peer trials

225 472nd of 2000 higher than 1,523 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03955445 · 225 participants · Phase 3

    Long-term Efficacy, Safety and Tolerability of Iptacopan in C3G or IC-MPGN

  • NCT04054310 · 225 participants · NA

    Non-Invasive Quantification of Liver Health in NASH (N-QUAN)

  • NCT04480554 · 225 participants · Phase 2

    Anti-retroviral Therapy, Medications for Opioid Use Disorder, Opioids and HIV Infection - Study 1

  • NCT04888104 · 225 participants

    Prospective, Multicenter, Case-Control Analysis of the VersaTie Posterior Fixation System to Prevent Proximal Junctional Failure in Long Posterior Spinal Fusion Constructs for Adult Patients

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01831921, the US trial registry maintained by the National Library of Medicine. NCT01831921 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.